These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7586076

  • 21. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW.
    J Med Chem; 1998 Jun 04; 41(12):2047-55. PubMed ID: 9622546
    [Abstract] [Full Text] [Related]

  • 22. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
    Suzuki T, Uesaka H, Hamajima H, Ikami T.
    Chem Pharm Bull (Tokyo); 1999 Jun 04; 47(6):876-9. PubMed ID: 10399839
    [Abstract] [Full Text] [Related]

  • 23. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
    Bymaster FP, Carter PA, Peters SC, Zhang W, Ward JS, Mitch CH, Calligaro DO, Whitesitt CA, DeLapp N, Shannon HE, Rimvall K, Jeppesen L, Sheardown MJ, Fink-Jensen A, Sauerberg P.
    Brain Res; 1998 Jun 08; 795(1-2):179-90. PubMed ID: 9622623
    [Abstract] [Full Text] [Related]

  • 24. The new muscarinic M1-receptor agonist YM796 evokes yawning and increases oxytocin secretion from the posterior pituitary gland in rats.
    Fujikawa M, Yamada K, Nagashima M, Domae M, Furukawa T.
    Pharmacol Biochem Behav; 1996 Sep 08; 55(1):55-60. PubMed ID: 8870038
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and muscarinic M3 pharmacological activities of 1-azabicyclo[2.2.2]octan-3-one oxime derivatives.
    Plate R, Plaum MJ, de Boer T, Andrews JS.
    Bioorg Med Chem; 1996 Feb 08; 4(2):239-45. PubMed ID: 8814881
    [Abstract] [Full Text] [Related]

  • 26. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J, Lembøl HL, Meier E, Pedersen H.
    Eur J Pharmacol; 1992 Jul 21; 218(1):159-69. PubMed ID: 1397027
    [Abstract] [Full Text] [Related]

  • 27. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May 21; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 28. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE, Hart JC, Bymaster FP, Calligaro DO, DeLapp NW, Mitch CH, Ward JS, Fink-Jensen A, Sauerberg P, Jeppesen L, Sheardown MJ, Swedberg MD.
    J Pharmacol Exp Ther; 1999 Aug 21; 290(2):901-7. PubMed ID: 10411607
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and muscarinic activities of 3-(pyrazolyl)-1,2,5,6-tetrahydropyridine derivatives.
    Plate R, Plaum MJ, de Boer T, Andrews JS, Rae DR, Gibson S.
    Bioorg Med Chem; 1996 Feb 21; 4(2):227-37. PubMed ID: 8814880
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and modeling studies of a potent conformationally rigid muscarinic agonist: 1-azabicyclo[2.2.1]heptanespirofuranone.
    Wu ES, Kover A, Semus SF.
    J Med Chem; 1998 Oct 22; 41(22):4181-5. PubMed ID: 9784090
    [No Abstract] [Full Text] [Related]

  • 31. 1,2,5-Thiadiazole derivatives of arecoline stimulate M1 receptors coupled to phosphoinositide turnover.
    Periyasamy S, Messer WS, Roknich S, Sauerberg P, Hoss W.
    Brain Res; 1995 Sep 25; 693(1-2):118-23. PubMed ID: 8653399
    [Abstract] [Full Text] [Related]

  • 32. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, Sheardown MJ, Swedberg MD, Suzdak PD, Sauerberg P.
    J Pharmacol Exp Ther; 1994 Apr 25; 269(1):271-81. PubMed ID: 7909557
    [Abstract] [Full Text] [Related]

  • 33. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .
    Bymaster FP, Shannon HE, Rasmussen K, Delapp NW, Mitch CH, Ward JS, Calligaro DO, Ludvigsen TS, Sheardown MJ, Olesen PH, Swedberg MD, Sauerberg P, Fink-Jensen A.
    Eur J Pharmacol; 1998 Sep 04; 356(2-3):109-19. PubMed ID: 9774240
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kakefuda A, Tanaka A, Takizawa K, Hirano S, Shibata H, Yamagiwa Y, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1998 Jan 04; 46(1):53-68. PubMed ID: 9468637
    [Abstract] [Full Text] [Related]

  • 35. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S, Angeli P, Bellucci C, Buccioni M, Gualtieri F, Marucci G, Manetti D, Matucci R, Romanelli MN, Scapecchi S, Teodori E.
    Biochem Pharmacol; 2005 Jun 01; 69(11):1637-45. PubMed ID: 15896343
    [Abstract] [Full Text] [Related]

  • 36. The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice.
    Sánchez C, Lembøl HL.
    Pharmacol Toxicol; 1994 Jan 01; 74(1):35-9. PubMed ID: 8159635
    [Abstract] [Full Text] [Related]

  • 37. Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat.
    Daws LC, Overstreet DH.
    Pharmacol Biochem Behav; 1999 Feb 01; 62(2):367-80. PubMed ID: 9972706
    [Abstract] [Full Text] [Related]

  • 38. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
    Fisher A, Bezprozvanny I, Wu L, Ryskamp DA, Bar-Ner N, Natan N, Brandeis R, Elkon H, Nahum V, Gershonov E, LaFerla FM, Medeiros R.
    Neurodegener Dis; 2016 Feb 01; 16(1-2):95-110. PubMed ID: 26606130
    [Abstract] [Full Text] [Related]

  • 39. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E, Barg J, Fisher A, Levy R, Pittel Z, Zimlichman R, Kushnir M, Vogel Z.
    Eur J Pharmacol; 1996 Feb 22; 297(3):283-91. PubMed ID: 8666061
    [Abstract] [Full Text] [Related]

  • 40. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M, Lazareno S, Pfaff O, Friebe T, Tastenoy M, Mutschler E, Lambrecht G.
    Br J Pharmacol; 1996 Dec 22; 119(7):1319-30. PubMed ID: 8968538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.